Holen Sie sich die Stockscreener-App
29.00
1.02%
-0.30
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
DEADLINE ALERT for HYLN, HIMS, UNCY, BIDU: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
Telehealth sector outlook: Doximity, Hims & Hers, and Teladoc compared By Investing.com - Investing.com Canada
Form 144 Hims & Hers Health For: 1 October By Investing.com - Investing.com Canada
Kaplan Fox Notifies Investors of Hims & Hers Health, Inc. (NYSE - The National Law Review
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - PR Newswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Hims & Hers appoints medical officers for UK and Australia - Investing.com UK
Rural Access, Digital Health, and What's Next with Matt Vickers, Chief Medical Officer of Hims Australia - Hims & Hers Newsroom
Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership - HIMS investor relations
Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership - The Joplin Globe
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Hims & Hers Goes GlobalRenewed Growth Prospects With Margin Risks (NYSE:HIMS) - Seeking Alpha
HIMS ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit before November 2, 2026 Deadline - PR Newswire
Is It Too Late to Buy Hims & Hers Health Inc (HIMS) After 3.8% R - GuruFocus
Hims & Hers: U.S. Revenue Reacceleration Is Reassuring, And Valuation Compression Is Compelling (Upgrade) - Seeking Alpha
Hims Stock Reclaims $30 and Attempts Breakout but Faces $35 Test - FXLeaders
Hims & Hers Health Rallies as Investors Appear to Reassess Recent Selloff - Quiver Quantitative
DEADLINE ALERT for YSS, HIMS, UNCY, and PZZA: The Law - GlobeNewswire
HIMS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Hims Inves - The National Law Review
Shareholders who lost money in shares of acquired Hims & - GlobeNewswire
HIMS & HERS HEALTH, INC. (HIMS) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Hims & Hers Health, Inc. Securities Fraud Class Action - GlobeNewswire
Robbins LLP Urges HIMS Stockholders to Contact the Firm for Information About the Hims & Hers Health, Inc. Class Action Lawsuit - PR Newswire
Deadline Alert: Hims & Hers Health, Inc. (HIMS) - GlobeNewswire
Hims & Hers Health (HIMS) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline - PR Newswire
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
INVESTOR ALERT: Hims & Hers Health, Inc. (NYSE: HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
What Do Today's Market Moves Mean for Hims & Hers Health (NYSE:HIMS)? - Kalkine Media
ROSEN, A LEADING NATIONAL FIRM, Encourages Hims & Hers - GlobeNewswire
Form 144 Hims & Hers Health For: 27 September By Investing.com - Investing.com Nigeria
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - Morningstar
Can Hims & Hers Health (HIMS) Stay Cheap As Sales Face Scrutiny? - Yahoo Finance
Form 4 Hims Hers Health Inc For: 26 September By Investing.com - Investing.com South Africa
Hims & Hers CFO Okupe sells $876,846 of HIMS stock - Investing.com
Hims & Hers Health (HIMS) Unveils AI Native Weight Loss Care Platform - Yahoo Finance
Kaplan Fox Advises Hims & Hers Health, Inc. (NYSE: HIMS) Investor - The National Law Review
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock DeclineInvestors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC - morningstar.com
2 Reasons to Like HIMS (and 1 Not So Much) - Yahoo Finance
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
HIMS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages HIMS Investors with Losses to Contact the Firm - GlobeNewswire
HIMS Stockholders Have Rights – If You Lost Money Investing - GlobeNewswire
INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 DeadlineHIMS - TMX Newsfile
Hims Launches AI-Native Weight Loss Care Platform Featuring Closed-Loop Action Engine and Clinical Escalation - HIT Consultant
Hims & Hers Health Inc (HIMS) Stock Up 3.1% and Still Undervalued -- GF Score: 77/100 - GuruFocus
Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (NYSE: HI - The National Law Review
Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks - MarketBeat
10 Health Care Stocks Whale Activity In Today’s Session - benzinga.com
Hims & Hers (HIMS) Shareholder Alert: Investigation of Potential Fiduciary Duty BreachesKehoe Law Firm, P.C. - The National Law Review
Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (NYSE: HIMS) With Significant Losses to a Securities Class Action Deadline on November 2, 2026 - Barchart.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Why Better Health Demands More than a Chatbot - Hims & Hers Newsroom
Kaplan Fox Alerts Hims & Hers Health, Inc. (NYSE: HIMS) Investors - The National Law Review
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS - PR Newswire
Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today - Yahoo Finance
Hims and Hers Is Scaling Rapidly, But Management Needs To Address The Difficult Questions - Yahoo Finance
Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, - GlobeNewswire
HIMS Shareholder Alert: Investigation of Potential - GlobeNewswire
1.15%
5.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):